ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $560,155 | -55.6% | 10,406 | -76.8% | 0.00% | -75.0% |
Q1 2022 | $1,261,000 | -75.5% | 44,863 | -59.8% | 0.00% | -63.6% |
Q4 2021 | $5,137,000 | +535.0% | 111,480 | +352.0% | 0.01% | +450.0% |
Q3 2021 | $809,000 | -35.9% | 24,663 | -31.5% | 0.00% | -33.3% |
Q2 2021 | $1,263,000 | -44.5% | 36,028 | -42.8% | 0.00% | -50.0% |
Q1 2021 | $2,277,000 | -3.2% | 63,016 | -22.2% | 0.01% | -14.3% |
Q4 2020 | $2,353,000 | +10.4% | 81,032 | +7.3% | 0.01% | -12.5% |
Q3 2020 | $2,131,000 | +0.8% | 75,535 | +15.5% | 0.01% | -20.0% |
Q2 2020 | $2,115,000 | +69.3% | 65,387 | +330.2% | 0.01% | +150.0% |
Q2 2019 | $1,249,000 | +84.5% | 15,200 | +58.3% | 0.00% | +100.0% |
Q1 2019 | $677,000 | -35.8% | 9,600 | -47.0% | 0.00% | -50.0% |
Q1 2018 | $1,054,000 | -1.9% | 18,100 | +8.6% | 0.00% | +33.3% |
Q4 2017 | $1,074,000 | +117.8% | 16,660 | +52.6% | 0.00% | +50.0% |
Q4 2015 | $493,000 | -68.8% | 10,916 | -61.1% | 0.00% | -77.8% |
Q4 2014 | $1,582,000 | +157.2% | 28,054 | +43.0% | 0.01% | +200.0% |
Q1 2014 | $615,000 | – | 19,613 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |